In English | En español
Questions About Cancer? 1-800-4-CANCER

Clinical Trials Search Results

Clinical Trials Search Results

Initial search results include only NCI-sponsored clinical trials. To search all trials, click the "REFINE SEARCH" button, scroll down to the Trial ID/Sponsor section and select the "All" check box in the Sponsor of Trial section.

View Content for:
Display:
  •          
Help with display options.
Results 1-25 of 99 for your search:
Keywords/Phrases:  cholangiocarcinoma
Trial Status:  Active
Start Over
        Show
1.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: Over 18
Sponsor: Other
Protocol IDs: 1111012021, NCT01524146

2.

Phase: No phase specified
Type: Natural history/Epidemiology
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: CHOLANGIO01, CHOLANGIO100513, NCT01920503

3.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: GATCO-1, NCT01043172

4.

Phase: Phase IV
Type: Supportive care
Status: Active
Age: 18 to 75
Sponsor: Other
Protocol IDs: SUMS-5010, Cholangiocarcinoma, Surgery, Drainage, NCT00797121

5.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: CBGJ398X2204, 2013-005085-19, NCT02150967

6.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 20140615, NCT02178280

7.

Phase: Phase III
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PIN-PHO1201, NCT02082522

8.

Phase: Phase III, Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 to 90
Sponsor: Other
Protocol IDs: XHDD-004, NCT02108145

9.

Phase: Phase III, Phase II
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: RFA2012, NCT01739465

10.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: GOX-P, S-20080081, 2612-3769, NCT00779454

11.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 to 80
Sponsor: Other
Protocol IDs: SUN-CK D09-2, 2011-000073-30, NCT01718327

12.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: H2009/3522, NCT00973713

13.

Phase: Phase II
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2010-020385-13, NCT01206049

14.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 65
Sponsor: Other
Protocol IDs: 2372P, NCT01549795

15.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 to 70
Sponsor: Other
Protocol IDs: 05-0651 / 201102096, NCT00301379

16.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2252P, NCT01442324

17.

Phase: Phase III, Phase II
Type: Supportive care
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 1110011999, NCT01755013

18.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: PrE0204, AX-CL-OTHER-PrECOG-004080, NCT02181634

19.

Phase: Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: NU 08I5, STU00007062, NCI-2009-01122, NCT00858429

20.

Phase: Phase II
Type: Treatment
Status: Approved-not yet active
Age: 30 to 65
Sponsor: Other
Protocol IDs: P-09-00171, NCT01039181

21.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 201111068, NCT01525069

22.

Phase: Phase II
Type: Biomarker/Laboratory analysis, Treatment
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 2012-EB-CHOL-Th, 2012-001213-16, A121007-71, NCT01912053

23.

Phase: No phase specified
Type: Treatment
Status: Active
Age: 17 to 60
Sponsor: Other
Protocol IDs: EHBH-RCT-2013-002-02, NCT01914289

24.

Phase: No phase specified
Type: Biomarker/Laboratory analysis, Natural history/Epidemiology
Status: Active
Age: 18 and over
Sponsor: Other
Protocol IDs: 21/2014/U/Tess, NCT02184871

25.

Phase: Phase II, Phase I
Type: Treatment
Status: Active
Age: 18 and over
Sponsor: Pharmaceutical / Industry
Protocol IDs: S4-13-001, NCT02128282
1     
New Search